Acellera’s Collaborations Sample Clauses

Acellera’s Collaborations. Since the beginning of the project, Acellera participated in the dissemination of the project news and promoted the use of in silico methods in industry and non-profit entities by participating and organising events, but especially by its effective marketing activity (during national and international events, such as congresses, and through their channels of digital marketing, such as Acellera website, LinkedIn and Twitter). This activity is illustrated by the organisation of workshops, its participation in workshops and its participation in various events and webinar (see Section 6.1.3). Acellera’s ISBA protocol has been optimized and is ready to initiate collaboration among CompBioMed partners. Discussions with CompBioMed partners Xxxxxx and Xxxxxxx were started to define the systems to study, the approach to consider, and the legal aspects when sharing technological or scientific knowledge among partners. Since simulations depend on the choice of molecule, emphasis has been put on the development of the protocol, particularly the sampling protocol (e.g.: Adaptive sampling, Adaptive Goal sampling) and its deployment to scale-up the simulations (clusters and Cloud). Today, these protocols are implemented in the software provided by Acellera and used both for services and internal research projects at Acellera. They demonstrated their robustness when predicting ligand binding site and reproducing the binding pathway and have proved to be applicable to a wide range of biomolecules. Moreover, Acellera provides free access through its platform XxxxXxxxxxxx.xxx to promote the use of in silico methods for drug discovery and molecular medicine projects (see statistics shared elsewhere). This platform encountered a large success since its release in June 2017. Between June 2017 and March 2019, the number of visits reached 16000 distributed including some 85% of non-profit entities’ users and 15% of industrial users, not only from large pharmaceutical companies but also SMEs. Several contacts were established with both large pharmaceutical companies and SMEs, showing a clear interest for the platform but also demonstrating the potential of the platform for visibility, testing and validating the interest for new applications or software in biomedicine. In order to propose a larger offering and more power for Cloud Computing, Acellera contacted CompBioMed’s Associate Partner Microsoft Azure. A recent (December 2018) collaboration has been set in order to promote Ace...
AutoNDA by SimpleDocs

Related to Acellera’s Collaborations

  • AREAS OF COLLABORATION The School will collaborate under Xxxx Innovation Mission to establish, operate and support ATL in India within the school premises with financial support from NITI Aayog.

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Research, Science and Technology Cooperation 1. The aims of cooperation in research, science and technology, carried out in the mutual interest of the Parties and in compliance with their policies, will be: (a) to build on existing agreements already in place for cooperation on research, science and technology; (b) to encourage, where appropriate, government agencies, research institutions, universities, private companies and other research organizations in the Parties to conclude direct arrangements in support of cooperative activities, programs or projects within the framework of this Agreement, specially related to trade and commerce; and (c) to focus cooperative activities towards sectors where mutual and complementary interests exist, with special emphasis on information and communication technologies and software development to facilitate trade between the Parties. 2. The Parties will encourage and facilitate, as appropriate, the following activities including, but not limited to:

  • Third Party Technology The Company makes use of third party technology to collect information required for traffic measurement, research, and analytics. Use of third party technology entails data collection. We therefore would like to inform clients the Company enables third parties to place or read cookies located on the browsers of users entering the Company’s domain. Said third parties may also use web beacons to collect information through advertising located on the Company’s web site. Please note that you may change your browser settings to refuse or disable Local Shared Objects and similar technologies; however, by doing so you may be disabling some of the functionality of Company’s services.

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Development of the Property Except as modified by this Agreement, the Development and the Property will be developed in accordance with all applicable local, state, and federal regulations, including but not limited to the City’s ordinances and the zoning regulations applicable to the Property, and such amendments to City ordinances and regulations that that may be applied to the Development and the Property under Chapter 245, Texas Local Government Code, and good engineering practices (the “Applicable Regulations”). If there is a conflict between the Applicable Regulations and the Development Standards, the Development Standards shall control.

  • Patent Rights The State and the U. S. Department of Transportation shall have the royalty free, nonexclusive and irrevocable right to use and to authorize others to use any patents developed by the Engineer under this contract.

  • Joint Inventions For Subject Inventions conceived or first actually reduced to practice under this Agreement that are joint Subject Inventions made by CONTRACTOR and USER, each Party shall have the option to elect and retain title to its undivided rights in such joint Subject Inventions.

Time is Money Join Law Insider Premium to draft better contracts faster.